3-iodo-alpha-methyltyrosine has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debus, J; Eisenhut, M; Haberkorn, U; Henze, M; Herfarth, KK; Mier, W; Mohammed, A; Schlemmer, H | 1 |
| Debus, J; Eisenhut, M; Haberkorn, U; Haufe, S; Henze, M; Herfarth, KK; Hoffner, S; Mier, W; Mohammed, A; Schlemmer, HP | 1 |
2 trial(s) available for 3-iodo-alpha-methyltyrosine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Follow-Up Studies; Humans; Male; Methyltyrosines; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
Topics: Adult; Astrocytoma; Female; Fluorodeoxyglucose F18; Humans; Male; Methyltyrosines; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |